Gene: CCN2
Official Full Name: cellular communication network factor 2provided by HGNC
Gene Summary: The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis. [provided by RefSeq, Nov 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08504 | CCN2 Knockout cell line (HeLa) | Human | CCN2 | 1:3~1:6 | Negative | Online Inquiry |
KO08505 | CCN2 Knockout cell line (HCT 116) | Human | CCN2 | 1:2~1:4 | Negative | Online Inquiry |
KO08506 | CCN2 Knockout cell line (HEK293) | Human | CCN2 | 1:3~1:6 | Negative | Online Inquiry |
KO08507 | CCN2 Knockout cell line (A549) | Human | CCN2 | 1:3~1:4 | Negative | Online Inquiry |
CCN2 Gene Knockout Cell Lines are genetically engineered cell models that specifically lack the CCN2 gene, which encodes the cellular communication network factor 2. This product serves as a critical tool for researchers investigating the multifaceted roles that CCN2 plays in cellular processes, including cell adhesion, migration, and proliferation, as well as its involvement in fibroblast activation and extracellular matrix regulation. By eliminating the CCN2 gene, scientists can explore the downstream effects of its absence, providing insights into pathological conditions such as fibrosis, cancer, and cardiovascular diseases.
The key functions of CCN2 are facilitated via its interactions with integrins and growth factor receptors, leading to the modulation of various signaling pathways. The knockout cell lines allow for the study of these downstream signaling events in conditions where CCN2 is not present, enabling researchers to elucidate the gene's contribution to disease progression and therapeutic responses.
Scientifically, CCN2 Gene Knockout Cell Lines are invaluable in research and clinical applications. They can be utilized to assess the potential of novel therapeutic agents aimed at targeting CCN2-related pathways, enabling drug development that could help mitigate complications that arise from excess CCN2 signaling. In addition, these knockout models provide a platform for personalized medicine initiatives by examining differential responses to treatments in cells that reflect varying levels of CCN2 expression.
Among their distinct advantages, these cell lines allow for reproducible and controlled experimentation in vitro, facilitating the comparison of responses between CCN2-deficient and wild-type cells. Compared to traditional models, the specificity of the knockout provides a clearer understanding of CCN2's role, enhancing the reliability and validity of experimental results.
For researchers and clinicians looking to deepen their understanding of fibrosis, cancer biology, or tissue repair mechanisms, the CCN2 Gene Knockout Cell Lines represent a robust, innovative solution that can aid in translating laboratory findings into potential therapeutic applications. Our company specializes in providing high-quality, advanced biological products, ensuring that your research is supported by validated models that embody scientific excellence and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.